News
CE Mark for Symmetry vagus nerve stimulation therapy to treat depression. - LivaNova PLC
LivaNova PLC a market-leading medical technology and innovation company, announced its Vagus Nerve Stimulation Therapy (VNS Therapy) System, Symmetry, earned CE Mark approval for Difficult-to-Treat Depression (DTD).
Now available in Europe, Symmetry is a small implantable device that stimulates the vagus nerve to improve symptoms of depression and quality of life. Symmetry sends mild electric pulses to the vagus nerve, which is connected to areas of the brain that control mood. While previous models of VNS Therapy have received CE Mark for the treatment of depression, Symmetry is specifically designed for the treatment of depression and is the newest VNS Therapy System. Symmetry also received U.S. FDA approval in September 2019.
Condition: Depression
Type: drug
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
2 mins